Males Females
Variables Mean ± S.D (mm) Mean ±S.D (mm)
  BST(N=62)  2MOT(N=39) ACT(N=49) BST(N=40) 2MOT(N=50) ACT(N=40)
BSF 5.37±1.57 5.69±1.57 5.57±1.73 5.09±1.08 4.83±0.98 6.54±1.25
TSF 4.37±1.87  5.16±2.20 5.70±1.87 7.37±1.74 7.66±1.31 8.33±1.16
SSSF 6.98±1.55   8.42±2.33 8.40±1.91 8.49±1.01 8.47±1.09 9.00±0.85
SISF 5.99±1.62 7.47±2.63 7.86±2.88 8.11±1.35 8.71±1.30 9.80±1.47
GMT 5.68±1.23 6.69±1.69  6.88±1.70 7.26±0.69 7.42 ± 0.81 8.42±0.76
Table 2: Skinfold thickness at different sites and grand mean thickness of the subjects at different stages of treatment. BST: Before Starting eatment; 2MOT: After completion of 2 months of Treatment; ACT: At the Completion of Treatment; BSF: Bicep Skinfold Thickness; TSF: Tricep Skinfold Thickness; SSSF: Subscapular Skinfold Thickness; Suprailiac Skinfold Thickness; GMT: Grand Mean Thickness.